Clinical Trial Update: Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update assesses the effect of Cangrelor on microvascular dysfunction during elective percutaneous coronary intervention in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cangrelor (cangrelor)

Snippet

Sponsor: Federico II University | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING